If RT002 were packaged as a prefilled syringe, its ability to be shipped and stored at room temperature would be even more of a benefit, compared to Botox.
Botox requires not only cold storage throughout the supply chain, but also an awkward needle-switching process for dilution and administration.
p.s. For modeling purposes, I consider the storage/handling advantage of RT002 relative to Botox as something that will be subsumed into the (as yet unknown) pricing differential.
Market Data 
Markets 
AI
